1-3 of 3
Kathrin H. Al-Ali, MD
Close
Sort by
Journal Articles

Immunochemotherapy (R-MCP) Is Not Superior to Chemotherapy (MCP) Alone in Advanced Mantle Cell Lymphoma - 42 Months Follow Up Results of the OSHO 39 Study.

Michael Herold, MD, Antje Haas, MD, Stephanie Srock, MD, Sabine Neser, MD, Kathrin H. Al Ali, MD, Andreas Neubauer, MD, Gottfried Doelken, MD, Ralph Naumann, MD, Thomas Fietz, MD, Mathias Freund, MD, Robert Rohrberg, MD, Klaus Hoeffken, MD, Martin Mohren, MD, Thomas H. Ittel, MD, Erika Kettner, MD
Journal: Blood
Blood (2007) 110 (11): 4474.
https://doi.org/10.1182/blood.V110.11.4474.4474
Published: 2007
Journal Articles

Addition of Rituximab to First-Line MCP (Mitoxantrone, Chlorambucil, Prednisolone) Chemotherapy Prolongs Survival in Advanced Follicular Lymphoma - 4 Year Follow-Up Results of a Phase III Trial of the East German Study Group Hematology and Oncology (OSHO#39).

Michael Herold, MD, Antje Haas, MD, Stephanie Srock, MD, Sabine Neser, MD, Kathrin H. Al Ali, MD, Andreas Neubauer, MD, Gottfried Doelken, MD, Ralph Naumann, MD, Thomas Fietz, MD, Mathias Freund, MD, Robert Rohrberg, MD, Klaus Hoeffken, MD, Astrid Franke, MD, Thomas H. Ittel, MD, Erika Kettner, MD
Journal: Blood
Blood (2006) 108 (11): 484.
https://doi.org/10.1182/blood.V108.11.484.484
Published: 2006
Journal Articles

Mesenchymal Stem Cells of Patients with Chronic Myeloid Leukemia Are Philadelphia Negative.

Chiara Gentilini, MD, Kathrin H. Al-Ali, MD, Annette Reinhardt, Kristina Bartsch, Toralf Lange, MD, Dietger W. Niederwieser
Journal: Blood
Blood (2004) 104 (11): 4683.
https://doi.org/10.1182/blood.V104.11.4683.4683
Published: 2004